Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Cao PG"" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł:
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases.
Autorzy:
Xie XY; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Peng HH; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China. .
Zhang X; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Pan YL; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Zhang Z; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Cao PG; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, People's Republic of China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Jul 26; Vol. 17 (1), pp. 132. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/secondary
Radiosurgery*
Brain/pathology ; Cranial Irradiation ; Humans ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease.
Autorzy:
Shang LL; Department of Intensive Medicine, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Ha'erbin, China.
Guo DD; Department of Cardiology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Ha'erbin, China.
Zhao HY; Department of Cardiology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Ha'erbin, China.
Quan AJ; Department of Intensive Medicine, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Ha'erbin, China.
Cao PG; Department of Cardiology, General Hospital of Heilongjiang Agricultural Reclamation Bureau, Ha'erbin, China.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2018 Jun; Vol. 43 (3), pp. 342-347. Date of Electronic Publication: 2017 Nov 17.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Adenosine/*analogs & derivatives
Coronary Disease/*therapy
Diabetes Mellitus, Type 2/*complications
Prasugrel Hydrochloride/*administration & dosage
Adenosine/administration & dosage ; Adenosine/pharmacology ; Aged ; Aspirin/administration & dosage ; Aspirin/pharmacology ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods ; Platelet Aggregation/drug effects ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/pharmacology ; Prasugrel Hydrochloride/pharmacology ; Prospective Studies ; Purinergic P2Y Receptor Antagonists/administration & dosage ; Purinergic P2Y Receptor Antagonists/pharmacology ; Thrombosis/etiology ; Thrombosis/prevention & control ; Ticagrelor ; Time Factors
Czasopismo naukowe
Tytuł:
Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.
Autorzy:
Wu A; Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
He S; Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.; Department of Plastic and Reconstructive Surgery, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Li J; Department of Pathology, Xiangya Basic Medical College, Central South University, Changsha, Hunan 410013, P.R. China.
Liu L; Department of Outpatients, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Liu C; Department of Gynaecology and Obstetrics, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Wang Q; Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Peng X; Department of Head and Neck Surgery and Oncology Plastic Surgery, The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, Hunan 410013, P.R. China.
Zhou J; Department of Plastic and Reconstructive Surgery, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Cao PG; Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Cao K; Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2017 Jun; Vol. 13 (6), pp. 4720-4726. Date of Electronic Publication: 2017 Apr 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2.
Autorzy:
Jin Q; Department of Oncology, Third Xiangya Hospital, Central South University, NO.138, Tong Zi Po Road, Yue Lu District, Chang Sha, Hunan Province, China 410013.
Li XJ; Department of Oncology, Third Xiangya Hospital, Central South University, NO.138, Tong Zi Po Road, Yue Lu District, Chang Sha, Hunan Province, China 410013.
Cao PG; Department of Oncology, Third Xiangya Hospital, Central South University, NO.138, Tong Zi Po Road, Yue Lu District, Chang Sha, Hunan Province, China 410013.
Pokaż więcej
Źródło:
Iranian journal of basic medical sciences [Iran J Basic Med Sci] 2016 Aug; Vol. 19 (8), pp. 851-857.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies